These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 31154270)

  • 1. Berberine treatment-emergent mild diarrhea associated with gut microbiota dysbiosis.
    Yue SJ; Liu J; Wang WX; Wang AT; Yang XY; Guan HS; Wang CY; Yan D
    Biomed Pharmacother; 2019 Aug; 116():109002. PubMed ID: 31154270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota.
    Chen H; Zhang F; Li R; Liu Y; Wang X; Zhang X; Xu C; Li Y; Guo Y; Yao Q
    Biomed Pharmacother; 2020 Apr; 124():109829. PubMed ID: 31958765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids.
    Yue SJ; Liu J; Wang AT; Meng XT; Yang ZR; Peng C; Guan HS; Wang CY; Yan D
    Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E73-E85. PubMed ID: 30422704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids.
    Yao Y; Chen H; Yan L; Wang W; Wang D
    Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis.
    Chen H; Zhang F; Zhang J; Zhang X; Guo Y; Yao Q
    Front Immunol; 2020; 11():588079. PubMed ID: 33072135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism.
    Wang Y; Shou JW; Li XY; Zhao ZX; Fu J; He CY; Feng R; Ma C; Wen BY; Guo F; Yang XY; Han YX; Wang LL; Tong Q; You XF; Lin Y; Kong WJ; Si SY; Jiang JD
    Metabolism; 2017 May; 70():72-84. PubMed ID: 28403947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites.
    Jing W; Dong S; Luo X; Liu J; Wei B; Du W; Yang L; Luo H; Wang Y; Wang S; Lu H
    Pharmacol Res; 2021 Feb; 164():105358. PubMed ID: 33285228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortex Phellodendri extract's anti-diarrhea effect in mice related to its modification of gut microbiota.
    Xu B; Yan Y; Huang J; Yin B; Pan Y; Ma L
    Biomed Pharmacother; 2020 Mar; 123():109720. PubMed ID: 31884345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice.
    Shi Y; Hu J; Geng J; Hu T; Wang B; Yan W; Jiang Y; Li J; Liu S
    Biomed Pharmacother; 2018 Nov; 107():1556-1563. PubMed ID: 30257374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine combined with stachyose induces better glycometabolism than berberine alone through modulating gut microbiota and fecal metabolomics in diabetic mice.
    Li CN; Wang X; Lei L; Liu MZ; Li RC; Sun SJ; Liu SN; Huan Y; Zhou T; Liu Q; Cao H; Bai GL; Han YW; Shen ZF
    Phytother Res; 2020 May; 34(5):1166-1174. PubMed ID: 31833107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effects of Berberine on the Gut Microbiota in Apc
    Wang H; Guan L; Li J; Lai M; Wen X
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30205580
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterizing the gut microbiota in patients with chronic kidney disease.
    Hu X; Ouyang S; Xie Y; Gong Z; Du J
    Postgrad Med; 2020 Aug; 132(6):495-505. PubMed ID: 32241215
    [No Abstract]   [Full Text] [Related]  

  • 13. Comprehensive evaluation of SCFA production in the intestinal bacteria regulated by berberine using gas-chromatography combined with polymerase chain reaction.
    Wang LL; Guo HH; Huang S; Feng CL; Han YX; Jiang JD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jul; 1057():70-80. PubMed ID: 28505492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine.
    Chen H; Ye C; Wu C; Zhang J; Xu L; Wang X; Xu C; Zhang J; Guo Y; Yao Q
    Int J Biol Sci; 2023; 19(7):2097-2113. PubMed ID: 37151876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota.
    Fang Y; Zhang J; Zhu S; He M; Ma S; Jia Q; Sun Q; Song L; Wang Y; Duan L
    Pharmacol Res; 2021 Mar; 165():105439. PubMed ID: 33493658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR's cholesterol-decreasing efficacy in patients.
    Wu C; Zhao Y; Zhang Y; Yang Y; Su W; Yang Y; Sun L; Zhang F; Yu J; Wang Y; Guo P; Zhu B; Wu S
    J Adv Res; 2022 Mar; 37():197-208. PubMed ID: 35499044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Panax ginseng polysaccharides on the gut microbiota in mice with antibiotic-associated diarrhea.
    Li S; Qi Y; Chen L; Qu D; Li Z; Gao K; Chen J; Sun Y
    Int J Biol Macromol; 2019 Mar; 124():931-937. PubMed ID: 30503788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response effect of berberine on bile acid profile and gut microbiota in mice.
    Guo Y; Zhang Y; Huang W; Selwyn FP; Klaassen CD
    BMC Complement Altern Med; 2016 Oct; 16(1):394. PubMed ID: 27756364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered gut microbiota in Rett syndrome.
    Strati F; Cavalieri D; Albanese D; De Felice C; Donati C; Hayek J; Jousson O; Leoncini S; Pindo M; Renzi D; Rizzetto L; Stefanini I; Calabrò A; De Filippo C
    Microbiome; 2016 Jul; 4(1):41. PubMed ID: 27473171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.